Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e8d2afa63dbd8bbb90545722d3f54c1 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96477 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-95 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2008-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65cee888c1777fe26ec86e7a117d3dbf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76e147ddfb849b80a4b0aa9c8aaad905 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_633de60a4a34344d7c6ef1760aee6da6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed3ea4e507d79845f9494dc247bc9f9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c95d2ec17fc67b65ae4cbc2b42db2c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f37addbf3a2d9fceee704ba5d394a64f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d8ab20d4ca55846f32d43960b03008a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db4e505141cdfddc580407632562ae7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e57a0d67d893b8b8638cdb7463249c7 |
publicationDate |
2010-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2010316635-A1 |
titleOfInvention |
Kit for diagnosis of breast cancer using herceptin, a composition comprising herceptin and a method for detecting herceptin-sensitive her2 overexpressed cell using the same |
abstract |
A kit and a composition comprising Herceptin, an antibody binding specifically to HER2, based on detecting Herceptin-sensitive HER2-overexpressing cells are provided for diagnosing cancer. A method of detecting Herceptin-sensitive HER2-overexpressing cells using the same is also provided. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2012133047-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5900489-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013012922-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8716014-B2 |
priorityDate |
2007-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |